Plasma mir-216a as a potential marker of pancreatic injury in a rat model of acute pancreatitis

World Journal of Gastroenterology

Volumn 16, Issue 36, 2010, Pages 4599-4604

  Kong, Xiang Yu ^a   Du, Yi Qi ^a   Li, Lei ^a   Liu, Jian Qiang ^b   Wang, Guo Kun ^a   Zhu, Jia Qi ^a   Man, Xiao Hua ^a   Gong, Yan Fang ^a   Xiao, Li Ning ^a   Zheng, Yong Zhi ^a   Deng, Shang Xin ^a   Gu, Jun Jun ^a   Li, Zhao Shen ^a  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

^b FUZHOU GENERAL HOSPITAL   (China)

Author keywords

Acute pancreatitis; Biomarker; Mir 216a; Pancreatic injury; Plasma mirna

Indexed keywords

AMYLASE; ARGININE; BIOLOGICAL MARKER; MICRORNA; MICRORNA 216A; TRIACYLGLYCEROL LIPASE; UNCLASSIFIED DRUG;

ACUTE PANCREATITIS; AMYLASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; MALE; NONHUMAN; PANCREAS INJURY; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ISOLATION; SEPSIS;

EID: 77957586272     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v16.i36.4599     Document Type: Article

References (24)

1. Griffiths-Jones S, Saini HK, van Dongen S, Enright AJ. miRBase: tools for microRNA genomics. Nucleic Acids Res 2008; 36: D154-D158
2. Hornstein E, Shomron N. Canalization of development by microRNAs. Nat Genet 2006; 38 Suppl: S20-S24
3. Jeyaseelan K, Lim KY, Armugam A. MicroRNA expression in the blood and brain of rats subjected to transient focal ischemia by middle cerebral artery occlusion. Stroke 2008; 39: 959-966
4. Ng EK, Chong WW, Jin H, Lam EK, Shin VY, Yu J, Poon TC, Ng SS, Sung JJ. Differential expression of microRNAs in plasma of patients with colorectal cancer: a potential marker for colorectal cancer screening. Gut 2009; 58: 1375-1381
5. Ji X, Takahashi R, Hiura Y, Hirokawa G, Fukushima Y, Iwai N. Plasma miR-208 as a biomarker of myocardial injury. Clin Chem 2009; 55: 1944-1949
6. Laterza OF, Lim L, Garrett-Engele PW, Vlasakova K, Muniappa N, Tanaka WK, Johnson JM, Sina JF, Fare TL, Sistare FD, Glaab WE. Plasma MicroRNAs as sensitive and specific biomarkers of tissue injury. Clin Chem 2009; 55: 1977-1983
7. Wichterman KA, Baue AE, Chaudry IH. Sepsis and septic shock--a review of laboratory models and a proposal. J Surg Res 1980; 29: 189-201
8. Mitchell RM, Byrne MF, Baillie J. Pancreatitis. Lancet 2003; 361: 1447-1455
9. Clavien PA, Burgan S, Moossa AR. Serum enzymes and other laboratory tests in acute pancreatitis. Br J Surg 1989; 76: 1234-1243
10. Andrejko KM, Chen J, Deutschman CS. Intrahepatic STAT-3 activation and acute phase gene expression predict outcome after CLP sepsis in the rat. Am J Physiol 1998; 275: G1423-G1429
11. Mitchell PS, Parkin RK, Kroh EM, Fritz BR, Wyman SK, Pogosova-Agadjanyan EL, Peterson A, Noteboom J, O'Briant KC, Allen A, Lin DW, Urban N, Drescher CW, Knudsen BS, Stirewalt DL, Gentleman R, Vessella RL, Nelson PS, Martin DB, Tewari M. Circulating microRNAs as stable blood-based markers for cancer detection. Proc Natl Acad Sci USA 2008; 105: 10513-10518
12. Wang GK, Zhu JQ, Zhang JT, Li Q, Li Y, He J, Qin YW, Jing Q. Circulating microRNA: a novel potential biomarker for early diagnosis of acute myocardial infarction in humans. Eur Heart J 2010; 31: 659-666
13. Shingara J, Keiger K, Shelton J, Laosinchai-Wolf W, Powers P, Conrad R, Brown D, Labourier E. An optimized isolation and labeling platform for accurate microRNA expression profiling. RNA 2005; 11: 1461-1470
14. Sood P, Krek A, Zavolan M, Macino G, Rajewsky N. Celltype-specific signatures of microRNAs on target mRNA expression. Proc Natl Acad Sci USA 2006; 103: 2746-2751
15. Baskerville S, Bartel DP. Microarray profiling of microRNAs reveals frequent coexpression with neighboring miRNAs and host genes. RNA 2005; 11: 241-247
16. Liang Y, Ridzon D, Wong L, Chen C. Characterization of microRNA expression profiles in normal human tissues. BMC Genomics 2007; 8: 166
17. Wang K, Zhang S, Marzolf B, Troisch P, Brightman A, Hu Z, Hood LE, Galas DJ. Circulating microRNAs, potential biomarkers for drug-induced liver injury. Proc Natl Acad Sci USA 2009; 106: 4402-4407
18. Ai J, Zhang R, Li Y, Pu J, Lu Y, Jiao J, Li K, Yu B, Li Z, Wang R, Wang L, Li Q, Wang N, Shan H, Li Z, Yang B. Circulating microRNA-1 as a potential novel biomarker for acute myocardial infarction. Biochem Biophys Res Commun 2010; 391: 73-77
19. Yadav D, Nair S, Norkus EP, Pitchumoni CS. Nonspecific hyperamylasemia and hyperlipasemia in diabetic ketoacidosis: incidence and correlation with biochemical abnormalities. Am J Gastroenterol 2000; 95: 3123-3128
20. Tietz NW, Huang WY, Rauh DF, Shuey DF. Laboratory tests in the differential diagnosis of hyperamylasemia. Clin Chem 1986; 32: 301-307
21. Salt WB 2nd, Schenker S. Amylase--its clinical significance: a review of the literature. Medicine (Baltimore) 1976; 55: 269-289
22. Tetrault GA. Lipase activity in serum measured with Ektachem is often increased in nonpancreatic disorders. Clin Chem 1991; 37: 447-451
23. Wong EC, Butch AW, Rosenblum JL. The clinical chemistry laboratory and acute pancreatitis. Clin Chem 1993; 39: 234-243
24. Lott JA, Speicher CE, Nemesánszky E. Is serum amylase an obsolete test in the diagnosis of acute pancreatitis? Arch Pathol Lab Med 1985; 109: 314-315